04/23/2026
We’re proud to share that DermaSensor has been selected as a TiE50 Awards Winner, recognizing innovative companies driving meaningful impact across industries.
As a first-of-its-kind, FDA-cleared device, DermaSensor is helping expand access to timely skin cancer risk assessment at the point of care.
Our CEO, Cody Simmons, will also be participating in a panel discussion at TiEcon 2026, taking place April 29 – May 1.
This recognition reflects the continued momentum behind advancing earlier detection and equipping clinicians with objective, real-time insights in everyday practice. 🚀